A patent examiner who questioned IP Australia’s examination processes has lost his appeal of a Fair Work Commission decision that found he was not forced to resign from his job.
Healthcare giant Johnson & Johnson is facing a new class action alleging it sold talcum powder that was contaminated with asbestos and caused reproductive system cancers in women.
A long-time Nine Network reporter has settled her sex discrimination claims against her former employer.
A judge has discontinued a second class action against Monsanto over its Roundup weed killer, but rejected the company’s bid for an order that group members be barred from bringing similar claims.
A Sydney lawyer who was found to have fleeced nearly $500,000 from his clients’ trust accounts has been declared unfit for the profession.
A pawn shop facing a class action lawsuit from customers who claim it gave them loans with annual interest rates of 480 per cent has failed to secure a court referral for pro bono lawyers.
A shareholder and creditor of failed energy company Armour Group will have to front $3.5 million in security in its case against law firm Baker McKenzie and others ahead of an upcoming trial.
Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.
Allens has advised Clean Energy Finance Corporation on a $1.9 billion investment in two Transgrid projects, one of which will connect Snowy Hydro 2.0 with Sydney and regional NSW.
Property fund manager GPT Group has announced it will increase its stake in Melbourne’s Highpoint Shopping Centre to 25 per cent in a $204.6 million transaction.